Skip to main content
Clinical Trials/IRCT20230714058773N4
IRCT20230714058773N4CompletedPhase 2

Comparison of celecoxib versus acetaminophen as pre-emptive analgesics for the management of post operative pain after impacted mandibular third molar surgery

Armed forces institute of dentistry CMH Rawalpindi0 sites75 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
17 years to 50 years (—)
Sex
All

Inclusion Criteria

  • •Male and female aged from 17 to 50 years old
  • •Patients with at least one impacted mandibular third molar that is indicated for surgical extraction and also confirmed by periapical radiographs including mesioangular, distoangular, horizontal and vertical impactions
  • •Patients with no intake of analgesic and anti-inflammatory drugs for 1 week.

Exclusion Criteria

  • •Patients with conditions in which the use of NSAIDs and COX-2 inhibitors is contraindicated.
  • •Patients with serious diseases like liver, kidney and cardiovascular diseases
  • •Pregnant or nursing women
  • •Patients with ulcers or bleeding in the digestive tract.
  • •Patients who are unable to express subjective discomfort symptoms.
  • •Patients with periodontal disease involving the adjacent teeth

Investigators

Sponsor
Armed forces institute of dentistry CMH Rawalpindi

Similar Trials